British Columbia-based Aurinia Pharmaceuticals has announced positive results from the fourth and final safety review of the company’s Phase 2b…
Articles by Margarida Azevedo
Researchers found that single-nucleotide polymorphisms (SNPs) at a specific genomic location, the FCGR2B-FCRLAÂ locus, is involved in the response of systemic…
Using next-generation DNA sequencing technology, researchers have targeted 16Â specific regions of the human genome associated with increased susceptibility to systemic…
Recent research highlights the understudied role of cytokines in various subtypes of cutaneous lupus erythematosus, primarily that cytokines interleukin-1 (IL-1-beta), interleukin-17…
Xencor announced the beginning of two Phase 2 clinical trials testing its drug candidate, XmAb5871, to treat systemic lupus erythematosus (SLE)…
Israel-based XTL Biopharmaceuticals, a clinical stage biotech company that focuses on the development of new drugs for the treatment of…
Researchers at Denmark’s Aarhus Research Center for Innate Immunology have discovered that the influenza virus has the ability to hide…
An international team of researchers has identified 10 new genes associated with the development of systemic lupus erythematosus (SLE) that might constitute potential…
Dr. Jill Kramer at the University of Buffalo School of Dental Medicine will lead a research study into the role of a…
Atherosclerosis is highly prevalent among Danish patients with systemic lupus erythematosus (SLE) without any history of cardiovascular disease (CVD), researchers at…